Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages

Journal of Controlled Release

Volumn 224, Issue , 2016, Pages 103-111

  Ngambenjawong, Chayanon ^a   Cieslewicz, Maryelise ^a   Schellinger, Joan G ^a,b   Pun, Suzie H ^a  

^a University of Washington   (United States)

^b UNIVERSITY OF SAN DIEGO   (United States)

Author keywords

M2 macrophages; Multivalent display; Targeted drug delivery

Indexed keywords

BINDING ENERGY; BINS; CELL CULTURE; COENZYMES; DISEASES; PEPTIDES; TOXICITY; TUMORS;

BINDING AFFINITIES; DISEASE PROGRESSION; IMMUNO MODULATIONS; MACROPHAGE TARGETING; MURINE MACROPHAGES; TARGETED DRUG DELIVERY; TUMOR ASSOCIATED MACROPHAGES; TUMOR MICROENVIRONMENT;

MACROPHAGES;

BIOTIN; M2PEP 2 KLA 2 PEPTIDE; M2PEP 2 KLA PEPTIDE; PEPTIDE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG POTENCY; DRUG SCREENING; DRUG SELECTIVITY; DRUG SYNTHESIS; DRUG TARGETING; FEMALE; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DEPLETION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; ANIMAL; APOPTOSIS; BONE MARROW CELL; C57BL MOUSE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HUMAN; MACROPHAGE; SYNTHESIS; TUMOR CELL LINE; TUMOR MICROENVIRONMENT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOTIN; BONE MARROW CELLS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; HUMANS; MACROPHAGES; MICE; MICE, INBRED C57BL; PEPTIDES; TUMOR MICROENVIRONMENT;

EID: 84954245344     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.12.057     Document Type: Article

References (44)

1. D.M. Pardoll Spinning molecular immunology into successful immunotherapy Nat. Rev. Immunol. 2 2002 227 238 10.1038/nri774
2. P. Sharma, K. Wagner, J.D. Wolchok, and J.P. Allison Novel cancer immunotherapy agents with survival benefit: recent successes and next steps Nat. Rev. Cancer 11 2011 805 812 10.1038/nrc3153
3. J.a. Joyce Therapeutic targeting of the tumor microenvironment Cancer Cell 7 2005 513 520 10.1016/j.ccr.2005.05.024
4. Y. Komohara, M. Jinushi, and M. Takeya Clinical significance of macrophage heterogeneity in human malignant tumors Cancer Sci. 105 2014 1 8 10.1111/cas.12314
5. Q. Lahmar, J. Keirsse, D. Laoui, K. Movahedi, E. Van Overmeire, and J.a.V. Ginderachter Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment Biochim. Biophys. Acta, Rev. Cancer 2015 10.1016/j.bbcan.2015.06.009
6. S.K. Biswas, and A. Mantovani Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm Nat. Immunol. 11 2010 889 896 10.1038/ni.1937
7. C. Lamagna, M. Aurrand-Lions, and B.A. Imhof Dual role of macrophages in tumor growth and angiogenesis J. Leukoc. Biol. 80 2006 705 713 10.1189/jlb.1105656
8. Q. Zhang, L. Liu, C. Gong, H. Shi, Y. Zeng, X. Wang, and et al. Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature PLoS ONE 7 2012 e50946 10.1371/journal.pone.0050946
9. E.K. Colvin Tumor-associated macrophages contribute to tumor progression in ovarian cancer Front. Oncol. 4 2014 137 10.3389/fonc.2014.00137
10. R. Cornelissen, L.a. Lievense, A.P. Maat, R.W. Hendriks, H.C. Hoogsteden, A.J. Bogers, and et al. Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma PLoS ONE 9 2014 e106742 10.1371/journal.pone.0106742
11. F. Pantano, P. Berti, F.M. Guida, G. Perrone, B. Vincenzi, M.M.C. Amato, and et al. The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients J. Cell. Mol. Med. 17 2013 1415 1421 10.1111/jcmm.12109
12. H. Kurahara, H. Shinchi, Y. Mataki, K. Maemura, H. Noma, F. Kubo, and et al. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer J. Surg. Res. 167 2011 211 219 10.1016/j.jss.2009.05.026
13. C. Medrek, F. Pontén, K. Jirström, and K. Leandersson The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients BMC Cancer 12 2012 306 10.1186/1471-2407-12-306
14. W. Zhou, S.Q. Ke, Z. Huang, W. Flavahan, X. Fang, J. Paul, and et al. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth Nat. Cell Biol. 17 2015 170 182 10.1038/ncb3090
15. S.M. Zeisberger, B. Odermatt, C. Marty, a.H.M. Zehnder-Fjällman, K. Ballmer-Hofer, and R.A. Schwendener Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach Br. J. Cancer 95 2006 272 281 10.1038/sj.bjc.6603240
16. S. Junankar, G. Shay, J. Jurczyluk, N. Ali, J. Down, N. Pocock, and et al. Real-time intravital imaging establishes tumor-associated macrophages as the extraskeletal target of bisphosphonate action in cancer Cancer Discov. 5 2014 35 42 10.1158/2159-8290.CD-14-0621
17. C.H. Ries, M.a. Cannarile, S. Hoves, J. Benz, K. Wartha, V. Runza, and et al. Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy Cancer Cell 25 2014 846 859 10.1016/j.ccr.2014.05.016
18. S.M. Pyonteck, L. Akkari, A.J. Schuhmacher, R.L. Bowman, L. Sevenich, D.F. Quail, and et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression Nat. Med. 19 2013 1264 1272 10.1038/nm.3337
19. A. Swierczak, A.D. Cook, J.C. Lenzo, C.M. Restall, J.P. Doherty, R.L. Anderson, and et al. The promotion of breast cancer metastasis caused by inhibition of CSF-1R/CSF-1 signaling is blocked by targeting the G-CSF receptor Cancer Immunol. Res. 2014 765 777 10.1158/2326-6066.CIR-13-0190
20. A. Casazza, D. Laoui, M. Wenes, S. Rizzolio, N. Bassani, M. Mambretti, and et al. Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity Cancer Cell 24 2013 695 709 10.1016/j.ccr.2013.11.007
21. C. Murdoch, A. Giannoudis, and C.E. Lewis Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues Blood 104 2004 2224 2234 10.1182/blood-2004-03-1109
22. D. Laoui, E. Van Overmeire, G. Di Conza, C. Aldeni, J. Keirsse, Y. Morias, and et al. Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population Cancer Res. 74 2014 24 30 10.1158/0008-5472.CAN-13-1196
23. M.R. Dreher, W. Liu, C.R. Michelich, M.W. Dewhirst, F. Yuan, and A. Chilkoti Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers J. Natl. Cancer Inst. 98 2006 335 344 10.1093/jnci/djj070
24. M. Cieslewicz, J. Tang, J.L. Yu, H. Cao, M. Zavaljevski, K. Motoyama, and et al. Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival Proc. Natl. Acad. Sci. U. S. A. 110 2013 15919 15924 10.1073/pnas.1312197110
25. C. Fasting, C.a. Schalley, M. Weber, O. Seitz, S. Hecht, B. Koksch, and et al. Multivalency as a chemical organization and action principle Angew. Chemie - Int. Ed. 51 2012 10472 10498 10.1002/anie.201201114
26. L. Locke, M. Mayo, A. Yoo, M. Williams, and S. Berr PET imaging of tumor associated macrophages using mannose coated 64 Cu liposomes Biomaterials 33 2012 7785 7793 10.1016/j.biomaterials.2012.07.022
27. S. Zhu, M. Niu, H. O'Mary, and Z. Cui Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles Mol. Pharm. 10 2013 3525 3530 10.1021/mp400216r
28. M. Niu, Y.W. Naguib, A.M. Aldayel, Y. Shi, S.D. Hursting, M.A. Hersh, and et al. Biodistribution and in vivo activities of tumor-associated macrophage-targeting nanoparticles incorporated with doxorubicin Mol. Pharm. 11 2014 4425 4436 10.1021/mp500565q
29. D.S.H. Chu, M.J. Bocek, J. Shi, A. Ta, C. Ngambenjawong, R.C. Rostomily, and et al. Multivalent display of pendant pro-apoptotic peptides increases cytotoxic activity J. Control. Release 205 2015 155 161 10.1016/j.jconrel.2015.01.013
30. L. Agemy Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma Proc. Natl. Acad. Sci. U. S. A. 108 2011 17450 17455 10.1073/pnas.1114518108 (/-/DCSupplemental.www.pnas.org/cgi/doi/10.1073/pnas.1114518108)
31. S. Hyun, S. Lee, S. Kim, S. Jang, J. Yu, and Y. Lee Apoptosis inducing, conformationally constrained, dimeric peptide analogs of KLA with submicromolar cell penetrating abilities Biomacromolecules 15 2014 3746 3752 10.1021/bm501026e
32. L. Adar, Y. Shamay, G. Journo, and A. David Pro-apoptotic peptide-polymer conjugates to induce mitochondrial-dependent cell death Polym. Adv. Technol. 22 2011 199 208 10.1002/pat.1829
33. D. Voulgaraki, R. Mitnacht-Kraus, M. Letarte, M. Foster-Cuevas, M.H. Brown, and a.N. Barclay Multivalent recombinant proteins for probing functions of leucocyte surface proteins such as the CD200 receptor Immunology 115 2005 337 346 10.1111/j.1365-2567.2005.02161.x
34. B.D. Polizzotti, and K.L. Kiick Effects of polymer structure on the inhibition of cholera toxin by linear polypeptide-based glycopolymers Biomacromolecules 7 2006 483 490 10.1021/bm050672n
35. D.V. Schaffer, and D.a. Lauffenburger Optimization of cell surface binding enhances efficiency and specificity of molecular conjugate gene delivery J. Biol. Chem. 273 1998 28004 28009 10.1074/jbc.273.43.28004
36. H.L. Handl, R. Sankaranarayanan, J.S. Josan, J. Vagner, E.a. Mash, R.J. Gillies, and et al. Synthesis and evaluation of bivalent NDP-alpha-MSH(7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R) Bioconjug. Chem. 18 2007 1101 1109 10.1021/bc0603642
37. T.-W. Chu, and J. Kopeček Drug-free macromolecular therapeutics - a new paradigm in polymeric nanomedicines Biomater. Sci. 2015 908 922 10.1039/C4BM00442F
38. K. Wu, J. Yang, J. Liu, and J. Kopeček Coiled-coil based drug-free macromolecular therapeutics: in vivo efficacy J. Control. Release 157 2012 126 131 10.1016/j.jconrel.2011.08.002
39. L. Jiang, L. Li, X. He, Q. Yi, B. He, J. Cao, and et al. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response Biomaterials 52 2015 126 139 10.1016/j.biomaterials.2015.02.004
40. H. Cheng, J.-Y. Zhu, X.-D. Xu, W.-X. Qiu, Q. Lei, K. Han, and et al. Activable cell-penetrating peptide (ACPP) conjugated prodrug for tumor targeted drug delivery ACS Appl. Mater. Interfaces 7 2015 16061 16069 10.1021/acsami.5b04517
41. C. Ding, J. Gu, X. Qu, and Z. Yang Preparation of multifunctional drug carrier for tumor-specific uptake and enhanced intracellular delivery through the conjugation of weak acid labile linker Bioconjug. Chem. 20 2009 1163 1170 10.1021/bc800563g
42. E.J. Paredes-Gamero, M.N.C. Martins, F.A.M. Cappabianco, J.S. Ide, and A. Miranda Characterization of dual effects induced by antimicrobial peptides: Regulated cell death or membrane disruption Biochim. Biophys. Acta, Gen. Subj. 1820 2012 1062 1072 10.1016/j.bbagen.2012.02.015
43. N. Itano, L. Zhuo, and K. Kimata Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression Cancer Sci. 99 2008 1720 1725 10.1111/j.1349-7006.2008.00885.x
44. N. Bertrand, J. Wu, X. Xu, N. Kamaly, and O.C. Farokhzad Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology Adv. Drug Deliv. Rev. 66 2014 2 25 10.1016/j.addr.2013.11.009